Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Find the Future of Outsourcing: Exploring the Gig Economy - 2Trump signs bill allowing whole milk to return to school lunches
- 3Tech Patterns 2023: 12 Advancements to Keep an eye Out For
- 44 astronauts depart ISS, leaving behind just 3 crewmates to staff the orbiting lab
- 5Find the Historical backdrop of Common liberties: Advancing Equity and Equity Around the world
- Sophie Kinsella, 'Confessions of a Shopaholic' author, dies at 55 after battle with cancer
- Our 10 favorite Space.com reader astronomy photos of 2025
- When preventable infections turn deadly behind bars | The Excerpt
- 8 Espresso Bean Starting points All over the Planet
- Find the Insider facts of Compelling Systems administration: Building Associations for Progress
- Reports: Germany plans expansion of foreign intelligence powers
- REWE launches seventh Pick&Go test store in Hanover
- Scientists solve the mystery of the prehistoric 'Burtele Foot'
- Hamas hands over another body in the Gaza Strip
